SUNOSI

This brand name is authorized in United States. It is also authorized in Austria, Croatia, Estonia, Finland, France, Ireland, Israel, Italy, Lithuania, Poland, UK.

Active ingredients

The drug SUNOSI contains one active pharmaceutical ingredient (API):

1	Solriamfetol UNII K7RO88SP7A - SOLRIAMFETOL HYDROCHLORIDE
	The mechanism(s) of solriamfetol to improve wakefulness in patients with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea has not been fully characterised. However, its efficacy could be mediated through its activity as a dopamine and norepinephrine reuptake inhibitor (DNRI).
	Read more about Solriamfetol

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
SUNOSI Film-coated tablet	MPI, US: SPL/PLR	FDA, National Drug Code (US)
SUNOSI Film-coated tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N06BA14		N Nervous system → N06 Psychoanaleptics → N06B Psychostimulants, agents used for ADHD and nootropics → N06BA Centrally acting sympathomimetics
Discover more medicines within N06BA14

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1810101, 1810112, 1810123, 1810134, 1810145, 1810156, 1810167, 1810178, 1810189, 1810190
FI	Lääkealan turvallisuus- ja kehittämiskeskus	155888, 380455
FR	Base de données publique des médicaments	64617815, 67314111
GB	Medicines & Healthcare Products Regulatory Agency	389254, 389257
IL	מִשְׂרַד הַבְּרִיאוּת	9302, 9303
IT	Agenzia del Farmaco	048446013, 048446025, 048446037, 048446049, 048446052, 048446064, 048446076, 048446088, 048446090, 048446102
LT	Valstybinė vaistų kontrolės tarnyba	1089305, 1089306, 1089307, 1089308, 1089309, 1089310, 1089311, 1089312, 1089313, 1089314
PL	Rejestru Produktów Leczniczych	100434474, 100434480
US	FDA, National Drug Code	68727-350, 68727-351